GMP IPO
📋 Filings Intelligence
About Contact
LIVE — Auto-updated every 10 mins · BSE Equity Only

BSE Exchange Filings, Explained Simply

AI-powered plain-English analysis of every important BSE announcement — financial results, order wins, dividends, mergers and more. Updated live.

Today
Total
BSE
Exchange
Sign in free to search by company
Filing Type
Market Cap
Sector
All Sectors

Latest Filings

📋 Filing Types Available on ForgeUp Filings Strictly sourced from BSE exchange announcements (equity segment only). We show only material, important filings.
Financial Results Orders Dividend Buyback Merger / Acquisition Board Meeting Outcome Fundraise (QIP / Rights / FPO) Regulatory / Court Order Credit Rating Change Promoter Pledge Update Management Change Joint Venture / MOU Delisting Bonus Shares Stock Split
Data sourced from BSE India exchange announcements. More categories will be added over time.
Simandhar Impex Ltd
Please find attached Outcome of Meeting of the Committee of Independent Directors for Open Offer held on April 15, 2026.
M&A ◆ Monitor Closely MEDIUM RISK
📅 Filed on BSE: 15 Apr 2026, 11:49 AM IST  ·  BSE ID: 51465685-314e-4f43-80ee-be457d39c838
View Original BSE Filing (PDF)
💡
In Simple Terms
The company's independent directors approved an outside firm's offer to buy over a quarter of the company's shares at Rs. 30 each.
🤖 AI Summary
  • Independent Directors approve Farmico's open offer for 7,75,310 shares (25.36% stake) at Rs. 30 per share
  • Committee concluded offer is fair and reasonable after review of all offer documents
  • Open Offer announcement made January 14, 2026; Detailed Statement published January 22, 2026
  • Letter of Offer issued April 4, 2026; Committee approval dated April 15, 2026
🔢 Key Numbers — exact figures from BSE filing, not rounded
Shares offered in open offer
7,75,310 equity shares
Percentage of fully paid-up voting capital
25.36%
Offer price per equity share
Rs. 30
Committee approval date
April 15, 2026
🏢 How This Affects the Company
📈
Business Impact
Approval of the open offer validates the acquisition process and moves it toward completion. Ownership structure change to 25.36% acquisition stake confirms strategic transaction progression.
👥 What This Means For Shareholders
Action Required
Shareholders should await formal open offer acceptance period announcement and tender documentation to participate or decline the offer.
👤
Who Is Affected
All equity shareholders of Simandhar Impex are affected. The offer targets acquisition of 7,75,310 shares at Rs. 30 per share, representing 25.36% of fully paid-up voting capital.
🔍
Management Signal
Independent director approval indicates management and board support for the acquisition transaction at the stated valuation.

For information only. Not investment advice. ForgeUp is not SEBI-registered.

👁 Watch List — track these upcoming events
Open offer acceptance announcement — track for shareholder participation timeline and acceptance status
Completion of open offer transaction — watch for Reg 31A(10) promoter reclassification filing
Post-offer shareholding pattern disclosure — monitor for final ownership structure confirmation
MEDIUM RISK Acquisition completion is not assured. Shareholder acceptance, regulatory clearance, and transaction execution remain pending.
💡 Investor Takeaway
Independent Directors Committee has formally approved Farmico International's open offer for 7,75,310 shares at Rs. 30 per share, representing 25.36% acquisition. Fair and reasonable assessment confirmed. Shareholder acceptance and completion status remain pending.
⚖️ Strengths & Concerns

✅ Positives

  • Independent committee approval demonstrates corporate governance compliance and fairness assessment of acquisition terms
  • Fair and reasonable conclusion by independent directors provides validation of Rs. 30 per share offer price
📅 Company Track Record
Simandhar Impex (CIN: U46498MH2023PLC415552) is a recently incorporated entity. Farmico International announced open offer January 14, 2026, at Rs. 30 per share for 25.36% stake acquisition. Independent director fairness assessment completed April 15, 2026.

Based on publicly available historical data. For context only.

⚠️ For Information Only — Not Investment Advice
ForgeUp Filings provides AI-generated summaries of public BSE exchange announcements (equity segment) for informational purposes only. Nothing here constitutes investment advice or a recommendation to buy, sell, or hold any security. ForgeUp is not a SEBI-registered investment advisor. All financial numbers are sourced directly from BSE filings and shown as-is. Past data is historical only. Please consult a qualified financial advisor before making investment decisions. Data sourced from BSE India public disclosures.
🔍
Sign in to use filters
Sign in free with Google to filter filings by category, market cap and sector — takes 5 seconds.